Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to reduction in lesion size and allowed some patients to avoid surgery, according to research from a phase I clinical trial ...
Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to a reduction in lesion size and allowed some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results